Crimean-Congo Hemorrhagic Fever Virus, Northeastern Greece by Papa, Anna et al.
LETTERS
in Mexico (6) and the United States 
(7). In the United States, several preg-
nant women died, and the hospitaliza-
tion rate for pregnant women was 4× 
higher than for the general population 
(8). Despite a fairly high birth rate on 
Reunion Island (19 births/1,000 popu-
lation), our small series does not sup-
port these ﬁ  ndings.
During the epidemic (July 20–
September 20, 2009), acute respiratory 
infections, including presumed cases 
of pandemic (H1N1) 2009, accounted 
for 20.6% of the total case load of 
physicians on the island. The attack 
rate was ≈12.9% among the 810,000 
inhabitants, and 8 deaths among per-
sons with conﬁ  rmed infection were re-
ported. Therefore, the minimal overall 
death rate was ≈7.5 per million popu-
lation and the case-fatality rate, 1 per 
10,000 population.
Bernard-Alex Gaüzère, 
Denis Malvy, Laurent Filleul, 
Duksha Ramful, 
Marie-Christine Jaffar-Bandjee, 
Mounir El Bock, 
Khaled Ezzedine, 
and David Vandroux
Author afﬁ   liations: Centre Hospitalier Ré-
gional de la Réunion, Saint-Denis, France 
(B.-A. Gaüzère, D. Ramful, M.-C. Jaffar-
Bandjee, D. Vandroux); Université Bordeaux 
2, Bordeaux, France (D. Malvy, K. Ezzedi-
ne); Cellule de l’Institut de Veille Sanitaire en 
Région, Saint Denis (L. Filleul); and Centre 
Hospitalier Régional de la Réunion, Saint-
Benoît, France (M. El Bock)
DOI: 10.3201/eid1701.100467
References
  1.   Chowell G, Bertozzi SM, Colchero MA, 
Lopez-Gatell H, Alpuche-Aranda C, Her-
nandez M, et al. Severe respiratory disease 
concurrent with the circulation of H1N1 
inﬂ  uenza. N Engl J Med. 2009;361:674–9. 
DOI: 10.1056/NEJMoa0904023
  2.   ANZIC Inﬂ  uenza Investigators, Webb SA, 
Pettilä V, Seppelt I, Bellomo R, Bailey M, 
et al. Critical care services and 2009 H1N1 
inﬂ  uenza in Australia and New Zealand. 
N Engl J Med. 2009;361:1925–34. DOI: 
10.1056/NEJMoa0908481
  3.   Kumar A, Zarychanski R, Pinto R, Cook 
DJ, Marshall J, Lacroix J, et al. Criti-
cally ill patients with 2009 inﬂ  uenza 
A(H1N1) infection in Canada. JAMA. 
2009;302:1872–9.  DOI: 10.1001/jama.
2009.1496
    4.    Rello J, Rodríguez A, Ibañez P, Socias 
L, Cebrian J, Marques A, et al. Intensive 
care adult patients with severe respiratory 
failure caused by inﬂ  uenza A (H1N1)v in 
Spain. Crit Care. 2009;13:R148.  DOI: 
10.1186/cc8044
  5.   Sakr Y, Madl C, Filipescu D, Moreno R, 
Groeneveld J, Artigas A, et al. Obesity is 
associated with increased morbidity but 
not mortality in critically ill patients. In-
tensive Care Med. 2008;34:1999–2009. 
DOI: 10.1007/s00134-008-1243-0
  6.   Perez-Padilla R, de la Rosa-Zamboni D, 
Ponce de Leon S, Hernandez M, Quiño-
nes-Falconi F, Bautista E, et al. Pneumo-
nia and respiratory failure from swine-ori-
gin inﬂ  uenza A (H1N1) in Mexico. N Engl 
J Med. 2009;361:680–9. DOI: 10.1056/
NEJMoa0904252
  7.   Centers for Disease Control and Preven-
tion. Intensive care patients with severe 
novel inﬂ  uenza A(H1N1) virus infection—
Michigan, June 2009. MMWR Morb Mor-
tal Wkly Rep. 2009;58:10.
    8.   Jamieson DJ, Honein MA, Rasmussen 
SA, Williams JL, Swerdlow DL, Bigger-
staff MS, et al. H1N1 2009 inﬂ  uenza virus 
infection during pregnancy in the USA. 
Lancet. 2009;374:451–8. DOI: 10.1016/
S0140-6736(09)61304-0
Address for correspondence: Bernard-Alex 
Gaüzère, CHR Réunion, Réanimation CH Félix 
Guyon, Saint-Denis 97405, Réunion; email: 
bernard.gauzere@chr-reunion.fr
Crimean-Congo 
Hemorrhagic Fever 
Virus, Northeastern 
Greece
To the Editor: Crimean-Congo 
hemorrhagic fever virus (CCHFV) 
causes a disease in humans that is 
characterized by fever and hemorrhag-
ic manifestations, with death rates up 
to 30%. Humans are infected through 
tick bites or contact with the viremic 
blood of patients or livestock. CCHFV 
belongs to the genus Nairovirus (fam-
ily  Bunyaviridae), which contains 7 
serogroups: CCHFV, Dugbe virus, 
Hughes virus, Sakhalin virus, Dera 
Ghazi Khan virus, Qalyub virus, and 
Thiafora virus.
A CCHFV strain, AP92, was iso-
lated from Rhipicephalus bursa ticks 
collected in 1975 from goats in Vergi-
na, a village in northern Greece (1). Se-
roprevalence among Vergina residents 
was 6.1% (2). During 1981–1988, the 
seroprevalence among 3,388 persons 
in Greece was 1.1% (range 0%–9.6%) 
(3). The ﬁ  rst Crimean-Congo hemor-
rhagic fever case in Greece was re-
ported in 2008, when a woman died in 
Komotini in northeastern Greece (4). 
The causative strain (Rodopi) differs 
from strain AP92 (5).
To determine the prevalence of 
CCHFV antibodies in the human 
population of northeastern Greece, se-
rum samples were collected prospec-
tively during November 2008–April 
2009 from 1,178 residents of Drama, 
Kavala, Xanthi, Rodopi, and Evros 
prefectures. A predeﬁ  ned number of 
participants were enrolled in the study 
on the basis of prefecture population. 
Participants were selected randomly 
among persons who were referred to 
health care settings for blood testing, 
regardless of reason for testing, and re-
gardless of CCHFV risk factors. Oral 
consent was given by all participants. 
A questionnaire was completed con-
cerning age, sex, occupation, place of 
residence, history of tick bite, symp-
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toms after the bite, contact with ani-
mals, and any other situation related 
with increased risk for tick bite. All 
age groups were included (range 0–97 
years, mean ± SE age 53.2 ± 0.63).
Serum samples were tested for 
CCHFV immunoglobulin (Ig) G by 
ELISA (Vektor-Best, Koltsovo, No-
vosibirsk, Russia). The data were ana-
lyzed by using Stata Special Edition 9 
(StataCorp LP, College Station, TX, 
USA). Multivariate logistic regres-
sion modeling was adopted to identify 
potential risk factors for acquisition of 
CCHFV infection. Odds ratios (ORs) 
with 95% conﬁ  dence intervals (CIs) 
were obtained. p values <0.05 were 
considered signiﬁ  cant.
In total, 37 (3.14%) of 1,178 per-
sons were positive for CCHFV by IgG. 
The mean ± SE age of seropositive 
and seronegative persons was 68.7 ± 
2.54 years (range 0–87 years) and 55.6 
± 0.79 years (range 0–97 years). The 
female:male ratio was 1.6 among test-
ed persons and 0.6 among seroposi-
tive persons. Seroprevalence differed 
among prefectures: Rodopi, where the 
fatal Crimean-Congo hemorrhagic fe-
ver case was observed, and Evros had 
the highest values (4.95% and 4.49%), 
Drama and Xanthi the lowest (1.34% 
and 1.09%), and no IgG-positive per-
son was found in Kavala. The distri-
bution of regions where IgG-positive 
persons were found is presented in the 
Figure. Seropositive persons lived in 
rural areas at an altitude of 10m to 270 
m; however, this factor was not sig-
niﬁ  cant (p = 0.358).
Crude analysis showed that age, 
sex, prefecture, occupation, contact 
with goats and sheep, slaughtering, 
and history of tick bite were signiﬁ  -
cantly associated with seropositivity. 
Multivariate analysis showed that the 
following variables were signiﬁ  cant 
risk factors for acquisition of CCHFV 
infection: age (OR 1.05, 95% CI 1.02–
1.08; p = 0.002), residence in Rodopi 
prefecture (with Drama prefecture as 
reference category) (OR 6.55, 95% 
CI 1.36–31.60; p = 0.019), contact 
with goats (OR 3.40, 95% CI 1.22–
9.43; p = 0.019), history of slaugh-
tering (OR 2.53, 95% CI 1.01–6.45; 
p = 0.048), and history of tick bite 
(OR 2.51, 95% CI 1.03–6.15; p = 
0.044).
When we compared our results 
with those of Antoniadis et al. (3), 
marked differences were seen: sero-
prevalence in Rodopi, Evros, Xan-
thi, and Drama was 0.5%, 0%, 1.2%, 
and 0%, respectively, compared with 
4.95%, 4.49%, 1.09%, and 1.34% in 
the present study, which suggests that 
during the past 20 years CCHFV was 
introduced in some areas in Greece or 
increased its circulation in others. Cli-
matic and environmental changes and 
infested livestock movements (legal 
or illegal) in a habitat suitable for ticks 
might play a role in the current situa-
tion (6).
Further studies are necessary to 
estimate the seroprevalence in the 
whole country and detect disease-en-
demic foci of the disease. In addition, 
surveys for CCHFV in Ixodid ticks 
are necessary to enable the construc-
tion of risk maps and risk assessment 
analysis.
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Figure. Five prefectures in northeastern Greece (inset), showing locations of persons 
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Class D OXA-48 
Carbapenemase in 
Multidrug-Resistant 
Enterobacteria, 
Senegal
To the Editor: Class D OXA 
β-lactamases are characterized as pen-
icillinases that can hydrolyze oxacillin 
and cloxacillin and are poorly inhib-
ited by clavulanic acid and EDTA. 
OXA-48 is one of the few members of 
this family to possess notable carbap-
enem-hydrolyzing activity (1). First 
described in 2004 in Turkey, OXA-48 
has recently started to spread in Europe 
and the Middle East (2). We report the 
recent emergence of the plasmid-en-
coded blaOXA-48 gene in multidrug-re-
sistant  Enterobacteriaceae recovered 
from patients in Dakar, Senegal, in 
hospitals and in the community. 
From November 2008 through 
October 2009, 11 Enterobacteriaceae 
isolates (8 Klebsiella pneumoniae, 1 
Escherichia coli, 1 Enterobacter cloa-
cae, and 1 Enterobacter sakazakii) 
with reduced susceptibility to imipen-
em were identiﬁ  ed at the Institut Pas-
teur (Dakar, Senegal). Antibacterial 
drug susceptibility was determined 
by the disk diffusion method and in-
terpreted according to the European 
Committee on Antimicrobial Suscep-
tibility Testing guidelines (www.eu-
cast.org). Nine isolates were resistant 
to expanded-spectrum cephalosporins 
and also to other antibacterial drug 
classes.
The isolates were recovered from 
6 patients with urinary tract infections, 
4 patients with surgical infections, and 
1 patient with omphalitis. Nine infec-
tions were hospital acquired (Le Dan-
tec and Principal Hospitals). Because 
the patients died before antibacterial 
drug susceptibility testing could be 
completed, all 5 patients with surgical 
infections or omphalitis received only 
empirical therapy with amoxicillin/
clavulanate. One patient with a noso-
comial urinary tract infection caused 
by a co-trimoxazole–susceptible strain 
was successfully treated with this an-
tibacterial agent. The antibacterial 
drug regimens of the remaining 4 pa-
tients were not known, and they were 
lost to follow-up. We determined the 
MICs of imipenem, meropenem, and 
ertapenem by using the Etest method 
(AB Biodisk, Solna, Sweden), which 
showed that 9 isolates were suscep-
tible to imipenem and meropenem 
but either intermediately susceptible 
or resistant to ertapenem (Table). The 
2 imipenem-nonsusceptible isolates 
were susceptible or intermediately 
susceptible to meropenem, and both 
were resistant to ertapenem. 
We used previously described   
PCRs (1,3–7) to screen for carbap-
enem-hydrolyzing β-lactamase genes 
(blaVIM, blaIMP, blaKPC, and blaOXA-48), 
as well as plasmid-encoded blaCTX-M, 
blaAmpC, blaOXA-1, and blaTEM  β-lactamase 
genes; the aac(6′)-Ib aminoglycoside 
resistance gene; the quinolone resis-
tance genes qnrA,B,S; the tetracycline 
resistance genes tetA,B,D; and class 
1 integron. The blaOXA-48,  blaCTX-M, 
blaAmpC, and aac(6′)-Ib genes and the 
variable region of class 1 integron 
were then characterized by direct 
DNA sequencing of the PCR products. 
blaOXA-48 was present in all 11 isolates. 
blaVIM, blaIMP, and blaKPC were not de-
tected. The qnr genes were present in 
7 isolates resistant to ciproﬂ  oxacin. 
The aac(6′)-Ib-cr variant was present 
in 7 isolates resistant to gentamicin, 
tobramycin, and ciproﬂ  oxacin.
The 9 isolates resistant to expand-
ed-spectrum cephalosporins all har-
bored the blaCTX-M-15 gene. The E. coli 
isolate also harbored the plasmid-en-
coded blaAmpC gene ACT-1; blaCTX-M-15, 
blaOXA-1, blaTEM, and aac(6′)lb-cr were 
associated in 6 isolates. Long-range 
PCRs showed that these latter 4 genes 
were located in the same “multidrug 
resistance region,” as described in Sen-
egal (6). Positive conjugation experi-
ments with sodium azide–resistant E. 
coli J53 showed through PCR results, 
plasmid DNA extraction, and antibio-
gram patterns of the obtained transcon-
jugants that blaOXA-48 was located on a 
70-kb self-conjugative plasmid. 
The genetic environment of 
blaOXA-48 was then investigated by PCR 
with primers speciﬁ  c for insertion se-
quence IS1999 and for the 5′ part of 
blaOXA-48 (1). blaOXA-48 was found to be 
part of a Tn1999 composite transposon 
composed of 2 copies of the insertion 
sequence IS1999, as reported (2). Fur-
ther sequencing of the IS1999 located 
upstream of blaOXA-48 showed that it 
was consistently truncated by the in-
sertion sequence IS1R, as initially de-
scribed in Turkey and more recently in 
Lebanon and Egypt (2,8).
XbaI pulsed-ﬁ  eld gel electropho-
resis was then used to study the genet-
ic relatedness of the 8 K. pneumoniae 
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